The Measles-Rubella and Inactivated Polio Vaccine (IPV) vaccination campaign in the ||Kharas Region got off to a smooth start, with health workers commending the positive public response on the first day of the campaign.

The Measles-Rubella vaccine is a combined injection design to protect children against viral infections of measles and rubella, while IPV protects children against polio.

All children from 6 months to 10 years will receive the measles-rubella vaccine, while the inactivated polio vaccine will be administered to children aged 14 weeks to 59 months.

The region aims to achieve a 96% measles-rubella vaccination rate.

Infection with measles can cause problems such as pneumonia, ear infections, sinus problems, seizures, brain damage, and possibly death.

Rubella can cause miscarriages, stillbirths, or birth defects in unborn babies.

The campaign ends Friday.